8-K: Xenon Pharmaceuticals Announces Details for 2025 Annual Shareholder Meeting

Xenon Pharmaceuticals has announced the date, record date, and other pertinent information regarding its 2025 annual meeting of shareholders.

Summary

• Xenon Pharmaceuticals Inc. announced details regarding its 2025 annual meeting of shareholders on March 14, 2025.
• The announcement was made via a filing submitted to the System for Electronic Document Analysis and Retrieval (SEDAR) in Canada.
• The annual meeting is scheduled for June 4, 2025.
• The record date for notice and voting is April 7, 2025.
• The beneficial ownership determination date is also April 7, 2025.
• Common shares are entitled to notice and to vote.
• The issuer will pay for objecting beneficial owner material distribution.
• The issuer is using notice-and-access for both registered and non-registered investors.

Sentiment

Score: 5

Explanation: The document is a routine announcement of an upcoming shareholder meeting, so the sentiment is neutral.

Positives

• The company is using notice-and-access, which can reduce printing and mailing costs.
• Xenon Pharmaceuticals will pay for material distribution to objecting beneficial owners, ensuring all shareholders have access to meeting information.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's financial performance or future prospects beyond the details of the annual meeting.

Industry Context

The announcement of an annual shareholder meeting is a standard corporate procedure. The use of notice-and-access is becoming increasingly common as companies seek to reduce costs and environmental impact.

Comparison to Industry Standards

• The use of notice-and-access for shareholder meetings is a common practice among publicly traded companies, aligning with industry standards for cost-effective communication.
• Companies like Pfizer, Johnson & Johnson, and Merck also utilize similar methods for their annual shareholder meetings.
• The specific dates and procedures for the meeting are typical for companies of Xenon's size and structure.

Stakeholder Impact

• Shareholders are informed about the upcoming annual meeting and their opportunity to vote on company matters.
• The use of notice-and-access may impact how some shareholders receive meeting materials.

Next Steps

• Shareholders should review the meeting materials when they become available.
• Shareholders should determine if they wish to vote and how they will cast their votes.

Key Dates